Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Cellectar Biosciences, Inc. | tm211114d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Cellectar Biosciences, Inc. | tm211114d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Cellectar Biosciences, Inc. | tm211114d1_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Cellectar Biosciences, Inc. | tm211114d1_ex21-1.htm |
| EX-4.4 - EXHIBIT 4.4 - Cellectar Biosciences, Inc. | tm211114d1_ex4-4.htm |
| 10-K - FORM 10-K - Cellectar Biosciences, Inc. | tm211114d1_10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Forms S-1 (File Nos. 333-221468, 333-214310, 333-214198, 333-208638, 333-225675, 333-231888, and 333-238132), Form S-3 (File Nos. 333-218514, 333-244362, and 333-252309) and Forms S-8 (File Nos. 333-221469, 333-195255, 333-164398, and 333-233460) of Cellectar Biosciences, Inc. and Subsidiary of our report dated March 2, 2021, relating to the consolidated financial statements which appears in this annual report on Form 10-K for the years ended December 31, 2020 and 2019.
| /s/ BAKER TILLY US, LLP (formerly known as BAKER TILLY VIRCHOW KRAUSE, LLP | |
| Madison, Wisconsin | |
| March 2, 2021 |